Richard Hobbs

96.9k total citations · 13 hit papers
557 papers, 24.0k citations indexed

About

Richard Hobbs is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Richard Hobbs has authored 557 papers receiving a total of 24.0k indexed citations (citations by other indexed papers that have themselves been cited), including 246 papers in Cardiology and Cardiovascular Medicine, 84 papers in Surgery and 78 papers in Epidemiology. Recurrent topics in Richard Hobbs's work include Blood Pressure and Hypertension Studies (93 papers), Heart Failure Treatment and Management (82 papers) and Atrial Fibrillation Management and Outcomes (67 papers). Richard Hobbs is often cited by papers focused on Blood Pressure and Hypertension Studies (93 papers), Heart Failure Treatment and Management (82 papers) and Atrial Fibrillation Management and Outcomes (67 papers). Richard Hobbs collaborates with scholars based in United Kingdom, United States and Qatar. Richard Hobbs's co-authors include Jonathan Mant, Andrea Roalfe, Jason Oke, Daniel Lasserson, Jennifer Hirst, Christopher A. O’Callaghan, Nathan R. Hill, Samuel Fatoba, David Fitzmaurice and Richard J. McManus and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Richard Hobbs

524 papers receiving 23.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis

2016 2.6k citations Jason Oke, Richard Hobbs et al. profile →
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

2007 1.1k citations Jonathan Mant, Richard Hobbs et al. profile →
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

2018 855 citations Annie Young, Andrea Marshall et al. Journal of Clinical Oncology profile →
International Clinical Recommendations on Scar Management

2002 746 citations Richard Hobbs et al. profile →
ESC/EAS Guidelines for the management of dyslipidaemias

2011 576 citations Richard Hobbs et al. profile →
Clinical workload in UK primary care: a retrospective analysis of 100 million consultations in England, 2007–14

2016 446 citations Richard Hobbs, Clare Bankhead et al. profile →
Survival of Patients with Chronic Heart Failure in the Community: A Systematic Review and Meta-Analysis

2019 348 citations Andrea Roalfe, Richard Hobbs et al. European Journal of Heart Failure profile →
Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study

2019 320 citations Clare Taylor, Andrea Roalfe et al. profile →
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

2021 180 citations Ly‐Mee Yu, Simon de Lusignan et al. profile →
Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses

2021 140 citations Richard Stevens, Richard J. McManus et al. profile →
Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial

2022 127 citations Richard Hobbs et al. profile →
Association between periodontal diseases and cardiovascular diseases, diabetes and respiratory diseases: Consensus report of the Joint Workshop by the European Federation of Periodontology (EFP) and the European arm of the World Organization of Family Doctors (WONCA Europe)

2023 124 citations Richard Hobbs et al. profile →
Periodontal diseases and cardiovascular diseases, diabetes, and respiratory diseases: Summary of the consensus report by the European Federation of Periodontology and WONCA Europe

2024 34 citations Richard Hobbs et al. profile →

Peers

Countries citing papers authored by Richard Hobbs

Since Specialization

Citations

This map shows the geographic impact of Richard Hobbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Hobbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Hobbs more than expected).

Fields of papers citing papers by Richard Hobbs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Hobbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Hobbs. The network helps show where Richard Hobbs may publish in the future.

Co-authorship network of co-authors of Richard Hobbs

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Hobbs. A scholar is included among the top collaborators of Richard Hobbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Hobbs. Richard Hobbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial 2024 ·The Lancet Healthy Longevity ·James P Sheppard, Eleanor Temple, Ariel Wang, Anne Smith, Stephanie Pollock, Gary A. Ford, Richard Hobbs, (unknown), Paul Little, Mark Lown, Simon de Lusignan, Jonathan Mant, David McCartney, Rupert Payne, Marney Williams, Ly‐Mee Yu, Richard J. McManus	6
2	The Association between Blood Test Trends and Undiagnosed Cancer: A Systematic Review and Critical Appraisal 2024 ·Cancers ·Pradeep S. Virdee, (unknown), Claire Friedemann Smith, Xin Yang, (unknown), (unknown), Nia Roberts, Jason Oke, Clare Bankhead, Rafael Perera, Richard Hobbs, Brian D Nicholson	3
3	Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetes 2023 ·Journal of Medical Economics ·Peter Rossing, (unknown), (unknown), Kerstin Folkerts, (unknown), James Harris, (unknown), (unknown), Örjan Åkerborg, Christoph Wanner, Richard Hobbs	5
4	A targeted approach to vaccine hesitancy 2023 ·PubMed ·(unknown), Simon de Lusignan, Richard Hobbs	0
5	COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: A national prospective cohort study 2023 ·Vaccine ·Stuart Bedston, Emily Lowthian, Christopher I Jarvis, Ashley Akbari, Jillian Beggs, Declan Bradley, Simon de Lusignan, Rowena Griffiths, (unknown), Richard Hobbs, Steven Kerr, Jane Lyons, (unknown), Rhiannon K Owen, Jennifer K Quint, Ruby S. M. Tsang, Fatemeh Torabi, Aziz Sheikh, Ronan A Lyons	4
6	Cost-Effectiveness of Antihypertensive Deprescribing in Primary Care: a Markov Modelling Study Using Data From the OPTiMISE Trial 2022 ·Hypertension ·Sue Jowett, (unknown), Gary A. Ford, Richard Hobbs, Mark Lown, Jonathan Mant, Rupert Payne, Richard J. McManus, James P Sheppard, (unknown)	7
7	A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post‐thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study) 2019 ·British Journal of Haematology ·Charlotte Bradbury, Kate Fletcher, Yongzhong Sun, Carl Heneghan, Chris Gardiner, Andrea Roalfe, Pollyanna Hardy, (unknown), (unknown), (unknown), Richard Hobbs, David Fitzmaurice	22
8	Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) breakdown → 2018 ·Journal of Clinical Oncology ·Annie Young, Andrea Marshall, (unknown), Oliver Chapman, Anand Lokare, Catherine St. Hill, Danielle Hale, Janet Dunn, Gary H. Lyman, Charles Hutchinson, Peter MacCallum, Ajay K. Kakkar, Richard Hobbs, Stavros Petrou, Jeremy Dale, Christopher Poole, Anthony Maraveyas, Mark N. Levine	855
9	Association of guideline and policy changes with incidence of lifestyle advice and treatment for uncomplicated mild hypertension in primary care: a longitudinal cohort study in the Clinical Practice Research Datalink 2018 ·BMJ Open ·James P Sheppard, Sarah Stevens, Richard Stevens, Jonathan Mant, Una Martin, Richard Hobbs, Richard J. McManus	9
10	What are General Practitioner perceptions of workload in England? A qualitative study 2017 ·British Journal of General Practice ·(unknown), Helen Ashdown, Richard Hobbs	3
11	Abstract 20082: Guideline-based Screening for Atrial Fibrillation: Analysis of Yield and Stroke Risk 2017 ·Circulation ·Nicole Lowres, David Fitzmaurice, Richard Hobbs, Femke Kaasenbrood, Vivian Lee, Robert G. Tieleman, Bryan P. Yan, Ben Freedman	2
12	Empress Eugénie and the Arts: Politics and Visual Culture in the Nineteenth Century Empress Eugénie and the Arts: Politics and Visual Culture in the Nineteenth Century . By Alison McQueen. Farnham: Ashgate, 2011. xx + 348 pp., ill. 2013 ·French Studies ·Richard Hobbs	1
13	Ten-Year Prognosis of Heart Failure in the Community: Follow-Up Data from the Echocardiographic Heart of England Screening (ECHOES) Study 2012 ·European Journal of Heart Failure ·Clare Taylor, Andrea Roalfe, (unknown), Richard Hobbs	51
14	Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation 2009 ·Stroke ·Carl van Walraven, Robert G. Hart, Stuart J. Connolly, Peter C. Austin, Jonathan Mant, Richard Hobbs, Peter J. Koudstaal, Palle Petersen, Francisco Pérez-Gómez, J. André Knottnerus, (unknown), Michael D. Ezekowitz, Daniel E. Singer	234
15	Statins in heart failure: Retrospective cohort study using routine primary care data 2009 ·Annals of Medicine ·Ronan Ryan, Richard J. McManus, Jonathan Mant, John Macleod, Richard Hobbs	5
16	Cardiologists' Awareness and Perceptions of Guidelines for Chronic Heart Failure. The ADDress Your Heart Survey 2008 ·European Journal of Heart Failure ·Leif Erhardt, Michel Komajda, Richard Hobbs, Jordi Soler‐Soler	33
17	The availability of inhaled human insulin may lead to a greater acceptance of insulin therapy in European type 2 diabetes patients failing on diet and/or oral agent therapy 2006 ·UCL Discovery (University College London) ·Nick Freemantle, Lawrence Blonde, Richard Hobbs, Marion Kvasz, (unknown), Samir A. Ross	1
18	The Diagnosis of Heart Failure in European Primary Care: The IMPROVEMENT Programme Survey of Perception and Practice 2005 ·European Journal of Heart Failure ·Richard Hobbs, J Korewicki, John G.F. Cleland, Joanne Eastaugh, Nick Freemantle	26
19	Guidelines and management of global risk: the European perspective 2004 ·European Heart Journal Supplements ·Richard Hobbs	1
20	Guidelines and management of global risk: the European perspective 2004 ·European Heart Journal Supplements ·Richard Hobbs	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact